Page last updated: 2024-08-24

fadrozole and Experimental Mammary Neoplasms

fadrozole has been researched along with Experimental Mammary Neoplasms in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19902 (20.00)18.7374
1990's8 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartz, U; Bayer, H; Grün, G; Hartmann, RW; Mitrenga, M; Sergejew, T1
Tsukagoshi, S1
Brodie, A; Savinov, A; Wang, J; Yue, W1
Hasegawa, Y; Nakao, K; Tanaka, M; Yano, S1
Durgam, VR; Tekmal, RR1
Horiuchi, R; Iino, Y; Maemura, M; Morishita, Y; Owada, S; Sato, H; Sugamata, N; Tago, T; Yokoe, T1
Hayashi, K; Kosaki, G; Shimozuma, K; Tominaga, T; Yoshida, Y1
Bhatnagar, AS; Bowman, R; Häusler, A; Lang, M; Schieweck, K1
el Etreby, MF; Michna, H; Nishino, Y; Schneider, MR1
Bhatnagar, AS; Matter, A; Schieweck, K1

Reviews

1 review(s) available for fadrozole and Experimental Mammary Neoplasms

ArticleYear
Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor.
    The Journal of steroid biochemistry and molecular biology, 1990, Dec-20, Volume: 37, Issue:6

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aromatase Inhibitors; Estrogen Antagonists; Estrogens; Fadrozole; Imidazoles; Letrozole; Mammary Neoplasms, Experimental; Nitriles; Steroids; Triazoles

1990

Trials

1 trial(s) available for fadrozole and Experimental Mammary Neoplasms

ArticleYear
[Introduction of a new aromatase inhibitor fadrozole hydrochloride hydsate].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:13

    Topics: Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Estrogen Antagonists; Fadrozole; Female; Humans; Mammary Neoplasms, Experimental; Rats

1995

Other Studies

8 other study(ies) available for fadrozole and Experimental Mammary Neoplasms

ArticleYear
Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 arom.
    Journal of medicinal chemistry, 1995, Jun-09, Volume: 38, Issue:12

    Topics: Adrenal Glands; Animals; Antineoplastic Agents; Aromatase Inhibitors; Cattle; Female; Humans; Liver; Male; Mammary Neoplasms, Experimental; Naphthalenes; Ovary; Placenta; Pyridines; Rats; Testis

1995
Effect of aromatase inhibitors on growth of mammary tumors in a nude mouse model.
    Cancer research, 1995, Jul-15, Volume: 55, Issue:14

    Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Cell Division; Fadrozole; Female; Letrozole; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Organ Size; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Triazoles; Uterus

1995
Antiproliferative effect of the new aromatase inhibitor fadrozole on pre- and postmenopausal models of rat mammary tumor.
    Arzneimittel-Forschung, 1994, Volume: 44, Issue:6

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Fadrozole; Female; Hormones; Mammary Neoplasms, Experimental; Menopause; Ovariectomy; Rats; Rats, Sprague-Dawley

1994
A novel in vitro and in vivo breast cancer model for testing inhibitors of estrogen biosynthesis and its action using mammary tumor cells with an activated int-5/aromatase gene.
    Cancer letters, 1997, Sep-16, Volume: 118, Issue:1

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoglutethimide; Analysis of Variance; Anastrozole; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Enzyme Inhibitors; Fadrozole; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Ovariectomy; Postmenopause; Triazoles; Tumor Cells, Cultured

1997
Antitumor effects of a nonsteroidal aromatase inhibitor (CGS 16949A) on 7, 12-dimethylbenz[alpha]anthracene-induced mammary tumors in rats.
    Japanese journal of clinical oncology, 1991, Volume: 21, Issue:3

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Aromatase Inhibitors; Body Weight; Estradiol; Estrone; Fadrozole; Female; Imidazoles; Mammary Neoplasms, Experimental; Nitriles; Organ Size; Progesterone; Rats; Rats, Inbred Strains; Receptors, Estrogen; Testosterone; Uterus

1991
Effect of CGS 16949A plus tamoxifen on induced mammary tumours in rats.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:5

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrone; Fadrozole; Female; Follicle Stimulating Hormone; Imidazoles; Luteinizing Hormone; Mammary Neoplasms, Experimental; Nitriles; Prolactin; Rats; Rats, Inbred Strains; Tamoxifen

1990
Antitumor effect of a specific aromatase inhibitor, 1-methyl-androsta-1,4-diene-3,17-dione (atamestane), in female rats bearing DMBA-induced mammary tumors.
    Journal of steroid biochemistry, 1989, Volume: 34, Issue:1-6

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Fadrozole; Female; Imidazoles; Mammary Neoplasms, Experimental; Nitriles; Rats; Rats, Inbred Strains

1989
CGS 16949A, a new nonsteroidal aromatase inhibitor: effects on hormone-dependent and -independent tumors in vivo.
    Cancer research, 1988, Feb-15, Volume: 48, Issue:4

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoglutethimide; Animals; Aromatase Inhibitors; Body Weight; Cell Line; Drug Screening Assays, Antitumor; Fadrozole; Female; Imidazoles; Mammary Neoplasms, Experimental; Nitriles; Rats; Tamoxifen

1988